BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19336542)

  • 1. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
    Slanger TE; Chang-Claude JC; Obi N; Kropp S; Berger J; Vettorazzi E; Braendle W; Bastert G; Hentschel S; Flesch-Janys D
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1188-96. PubMed ID: 19336542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
    Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
    Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between common risk factors and molecular subtypes in breast cancer patients.
    Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
    Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
    JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
    Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
    Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
    Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.
    Nyante SJ; Dallal CM; Gierach GL; Park Y; Hollenbeck AR; Brinton LA
    Am J Epidemiol; 2013 Aug; 178(3):359-71. PubMed ID: 23899816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
    Li CI; Malone KE; Porter PL; Lawton TJ; Voigt LF; Cushing-Haugen KL; Lin MG; Yuan X; Daling JR
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):43-50. PubMed ID: 18199710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
    Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
    J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.
    Li CI; Daling JR; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Strom BL; Simon MS; Press MF; McDonald JA; Ursin G; Burkman RT; Deapen D; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):946-54. PubMed ID: 16702375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
    Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
    Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
    Li CI; Weiss NS; Stanford JL; Daling JR
    Cancer; 2000 Jun; 88(11):2570-7. PubMed ID: 10861435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States).
    Newcomer LM; Newcomb PA; Potter JD; Yasui Y; Trentham-Dietz A; Storer BE; Longnecker MP; Baron JA; Daling JR
    Cancer Causes Control; 2003 Apr; 14(3):225-33. PubMed ID: 12814201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for ductal and lobular breast cancer: results from the nurses' health study.
    Kotsopoulos J; Chen WY; Gates MA; Tworoger SS; Hankinson SE; Rosner BA
    Breast Cancer Res; 2010; 12(6):R106. PubMed ID: 21143857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
    Fournier A; Fabre A; Mesrine S; Boutron-Ruault MC; Berrino F; Clavel-Chapelon F
    J Clin Oncol; 2008 Mar; 26(8):1260-8. PubMed ID: 18323549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between menopausal symptoms and risk of postmenopausal breast cancer.
    Huang Y; Malone KE; Cushing-Haugen KL; Daling JR; Li CI
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):379-88. PubMed ID: 21212063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A; Christensen J; Thomsen BL; Olsen A; Overvad K; Ewertz M; Mellemkjaer L
    Cancer; 2004 Jun; 100(11):2328-37. PubMed ID: 15160335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.